1. Rychlik, Michal, Starowicz, Gabriela, Starnowska-Sokol, Joanna, Mlyniec, Katarzyna. 2022. The Zinc-sensing Receptor (GPR39) Modulates Declarative Memory and Age-related Hippocampal Gene Expression in Male Mice. In Neuroscience, 503, 1-16. doi:10.1016/j.neuroscience.2022.09.002. https://pubmed.ncbi.nlm.nih.gov/36087899/
2. Grunddal, Kaare V, Diep, Thi A, Petersen, Natalia, Cox, Helen, Holst, Birgitte. 2021. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist. In Molecular metabolism, 49, 101207. doi:10.1016/j.molmet.2021.101207. https://pubmed.ncbi.nlm.nih.gov/33711555/
3. Hua, Dongxu, Huang, Wanlin, Xie, Qiyang, Li, Peng, Sheng, Yanhui. 2024. Targeting GPR39 in structure-based drug discovery reduces Ang II-induced hypertension. In Communications biology, 7, 1441. doi:10.1038/s42003-024-07132-2. https://pubmed.ncbi.nlm.nih.gov/39500998/
4. Kolodziejski, Pawel Antoni, Pruszynska-Oszmalek, Ewa, Sassek, Maciej, Strowski, Mathias Z, Nowak, Krzysztof W. 2016. Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes. In Journal of diabetes, 9, 353-361. doi:10.1111/1753-0407.12417. https://pubmed.ncbi.nlm.nih.gov/27106635/